文献速递精神分裂症与精神病性障碍

抗精神病药长期调节D2/D3受体对健康人认知功能的因果影响

Effects of antipsychotics on human cognitive function: causal evidence from healthy volunteers following sustained D2/D3 antagonism, D2/D3 partial agonism and placebo.
PubMed 文献 · Mol Psychiatry · 2025-07-19

该双盲安慰剂对照交叉研究在50名健康人中持续7天给予氨磺必利(D2/D3拮抗剂,400 mg/日)或阿立哌唑(D2/D3部分激动剂,10 mg/日),发现两者均损害视空间工作记忆的平衡整合分数和反应潜伏期,但不影响反应准确性和持续注意。

要点

  • 氨磺必利和阿立哌唑均损害视空间工作记忆功能,表现为平衡整合分数下降和反应潜伏期延长。
  • 两种药物均不影响视空间工作记忆的反应准确性、持续注意或主观警觉性。
  • 反应潜伏期缺陷与药物引起的运动障碍不相关,提示工作记忆损害具有特异性。

核心结论

  • 在健康人中,持续7天使用氨磺必利或阿立哌唑均导致视空间工作记忆功能受损,但不引起广泛认知或运动缺陷。

研究设计与样本

  • 双盲、安慰剂对照交叉研究,两个独立健康人样本共50人,每个条件持续7天给药。

主要发现

  • 氨磺必利(400 mg/日)和阿立哌唑(10 mg/日)均损害视空间工作记忆的平衡整合分数(氨磺必利p=0.0079;阿立哌唑p=0.015)。
  • 两种药物均延长视空间工作记忆反应潜伏期(氨磺必利p=5.5×10-7;阿立哌唑p=0.022),但不影响反应准确性。
  • 反应潜伏期缺陷与药物引起的运动障碍不相关,且两种药物对持续注意任务和主观警觉性均无影响。

关键数值与推荐

  • 氨磺必利剂量为400 mg/日,阿立哌唑剂量为10 mg/日,均持续给药7天。
  • 认知评估采用计算机化视空间工作记忆任务和持续注意反应任务。
  • 视空间工作记忆平衡整合分数损害:氨磺必利p=0.0079,阿立哌唑p=0.015。
  • 视空间工作记忆反应潜伏期损害:氨磺必利p=5.5×10-7,阿立哌唑p=0.022。

临床怎么用

  • 临床使用氨磺必利或阿立哌唑时需关注视空间工作记忆可能受损,尤其是反应速度下降。
  • 认知损害与运动障碍不相关,提示需独立评估工作记忆功能。

局限性

  • 研究仅纳入健康人,样本量共50人,结果外推至患者需谨慎。
  • 仅评估7天持续给药后的认知功能,未涉及长期用药影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dopamine D2/D3 receptor modulation with antipsychotics is thought to affect cognitive function, but causal evidence in humans is scant, and largely limited to single administrations. Clarifying this is of importance given the widespread use of antipsychotics, and to understand the role of D2/D3 signalling in human cognition. We therefore conducted a double-blind, placebo-controlled crossover study following sustained administration of either a dopamine D2/D3 receptor antagonist (amisulpride at 400 mg daily) or a D2/D3 partial agonist (aripiprazole at 10 mg daily) to two separate samples of healthy humans (total n = 50) for 7 days per condition. We assessed cognitive function using a computerised visuospatial working memory (VS-WM) task, and sustained attention and response inhibition using the Sustained Attention to Response Task (SART). We found that both amisulpride and aripiprazole caused impairments in VS-WM function compared to placebo on the Balanced Integration Score (amisulpride: p = 0.0079; aripiprazole: p = 0.015). Both antipsychotics impaired VS-WM performance in terms of response latency (amisulpride: p = 5.5 × 10-7; aripiprazole: p = 0.022), but did not affect response accuracy. Response latency deficits were not correlated with motor impairments induced by either drug, and we also found no effect of either drug on the SART measures, or on subjective alertness, suggesting that D2/D3 antagonism or partial agonism did not cause a generalised cognitive or motor deficit but specifically impaired cognition during VS-WM. This study provides the first causal evidence in healthy humans that working memory function is impaired following either sustained antagonism or partial agonism of D2/D3 receptors by antipsychotic drugs.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Osugo M, Zahid U, Selvaggi P, et al. Effects of antipsychotics on human cognitive function: causal evidence from healthy volunteers following sustained D2/D3 antagonism, D2/D3 partial agonism and placebo. Mol Psychiatry. 2025. PMID: 40684007. doi:10.1038/s41380-025-03116-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。